美国FDA已批准医学影像人工智能算法的临床验证与使用趋势
97个(64.2%)报告使用临床数据验证设备。
要点
- 多数FDA摘要提及临床数据验证,但人口学与设备信息极少披露。
- 仅约三分之一设备标注多中心临床数据,多数未说明中心数。
- 参考标准仅在约半数摘要中明确,影响验证可重复性评估。
诊断标准与关键数值
- 97个(64.2%)报告使用临床数据验证设备。
- 6个(4%)披露研究参与者人口学特征。
- 8个(5.3%)报告所用机器规格。
- 51个(33.8%)标注多中心临床数据,3个(2%)单中心,97个(64.2%)未说明。
- 78个(51.6%)明确临床验证所用参考标准。
临床应用与阅片要点
- 阅片时需注意AI设备的临床验证信息是否完整,尤其人口学与设备规格。
- 报告引用AI结果时应关注其验证中心数与参考标准是否明确。
局限性
- 回顾性研究,仅基于FDA公开摘要,信息受限于摘要披露内容。
- 未评估算法性能指标或临床影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
AIM: To examine the current landscape of US Food and Drug Administration (FDA)-approved artificial intelligence (AI) medical imaging devices and identify trends in clinical validation strategy.
MATERIALS AND METHODS: A retrospective study was conducted that analysed data extracted from the American College of Radiology (ACR) Data Science Institute AI Central database as of November 2021 to identify trends in FDA clearance of AI products related to medical imaging. Product and clinical validation information of each device was gathered from their respective public 510(k) summary or de novo request submission, depending on their type of authorisation.
RESULTS: Overall, the database included a total of 151 AI algorithms that were cleared by the FDA between 2008 and November 2021. Out of the 151 FDA summaries reviewed, 97 (64.2%) reported the use of clinical data to validate their device, with six (4%) revealing study participant demographics, and eight (5.3%) reporting the specifications of the machines used. A total of 51 (33.8%) AI devices characterised their clinical data as multicentre, three (2%) as single-centre, and the remaining 97 (64.2%) did not specify. The ground truth used for clinical validation was specified in 78 (51.6%) FDA summaries.
CONCLUSION: A wide breadth of AI algorithms has been developed for medical imaging. Most of the FDA summaries of the devices mention their use of clinical data and patient cases for device validation; however, few devices revealed the patient demographics or machine specifications used in their clinical studies, which may lead some consumers to question their external validation.
引用
- Khunte, Chae, Wang, et al. Trends in clinical validation and usage of US Food and Drug Administration-cleared artificial intelligence algorithms for medical imaging. Clin Radiol. 2022. PMID: 36625218. doi:10.1016/j.crad.2022.09.122
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。